Akili, Inc. Logo

Akili, Inc.

AKLI

(2.2)
Stock Price

0,43 USD

-72.06% ROA

-74.46% ROE

-0.7x PER

Market Cap.

34.096.536,00 USD

24.03% DER

0% Yield

-2492.04% NPM

Akili, Inc. Stock Analysis

Akili, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Akili, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (78.03%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

3 PBV

The stock's low PBV ratio (0.43x) suggests it's undervalued, making it an attractive opportunity for investors.

4 DER

The stock has a minimal amount of debt (23%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

5 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Akili, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Akili, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Akili, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Akili, Inc. Revenue
Year Revenue Growth
2019 19.986.000
2020 3.939.000 -407.39%
2021 538.000 -632.16%
2022 323.000 -66.56%
2023 2.808.000 88.5%
2023 1.678.000 -67.34%
2024 1.532.000 -9.53%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Akili, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2019 21.265.000
2020 15.418.000 -37.92%
2021 18.234.000 15.44%
2022 28.858.000 36.81%
2023 19.648.000 -46.88%
2023 19.925.000 1.39%
2024 16.732.000 -19.08%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Akili, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2019 18.877.000
2020 13.541.000 -39.41%
2021 29.779.000 54.53%
2022 53.840.000 44.69%
2023 0 0%
2023 38.839.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Akili, Inc. EBITDA
Year EBITDA Growth
2019 -20.213.000
2020 -25.012.000 19.19%
2021 -60.423.000 58.61%
2022 -90.677.000 33.36%
2023 -69.392.000 -30.67%
2023 -60.143.000 -15.38%
2024 -40.492.000 -48.53%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Akili, Inc. Gross Profit
Year Gross Profit Growth
2019 18.644.000
2020 3.523.000 -429.21%
2021 183.000 -1825.14%
2022 -118.000 255.08%
2023 1.688.000 106.99%
2023 859.000 -96.51%
2024 840.000 -2.26%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Akili, Inc. Net Profit
Year Net Profit Growth
2019 -20.634.000
2020 -25.646.000 19.54%
2021 -61.830.000 58.52%
2022 -7.964.000 -676.37%
2023 -63.504.000 87.46%
2023 -59.493.000 -6.74%
2024 -39.052.000 -52.34%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Akili, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2019 0
2020 0 0%
2021 -2 100%
2022 0 0%
2023 -1 0%
2023 -1 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Akili, Inc. Free Cashflow
Year Free Cashflow Growth
2019 -29.842.000
2020 -24.667.000 -20.98%
2021 -54.474.000 54.72%
2022 -83.563.000 34.81%
2023 -18.048.000 -363%
2023 -58.010.000 68.89%
2024 -10.226.000 -467.28%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Akili, Inc. Operating Cashflow
Year Operating Cashflow Growth
2019 -29.381.000
2020 -24.551.000 -19.67%
2021 -53.982.000 54.52%
2022 -83.521.000 35.37%
2023 -18.045.000 -362.85%
2023 -57.867.000 68.82%
2024 -9.996.000 -478.9%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Akili, Inc. Capital Expenditure
Year Capital Expenditure Growth
2019 461.000
2020 116.000 -297.41%
2021 492.000 76.42%
2022 42.000 -1071.43%
2023 3.000 -1300%
2023 143.000 97.9%
2024 230.000 37.83%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Akili, Inc. Equity
Year Equity Growth
2019 -82.248.000
2020 -104.902.000 21.6%
2021 65.762.000 259.52%
2022 110.679.000 40.58%
2023 58.532.000 -89.09%
2023 69.094.000 15.29%
2024 50.208.000 -37.62%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Akili, Inc. Assets
Year Assets Growth
2019 43.538.000
2020 20.181.000 -115.74%
2021 80.937.000 75.07%
2022 144.557.000 44.01%
2023 80.383.000 -79.84%
2023 93.142.000 13.7%
2024 67.365.000 -38.26%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Akili, Inc. Liabilities
Year Liabilities Growth
2019 125.786.000
2020 125.083.000 -0.56%
2021 15.175.000 -724.27%
2022 33.878.000 55.21%
2023 21.851.000 -55.04%
2023 24.048.000 9.14%
2024 17.157.000 -40.16%

Akili, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.02
Net Income per Share
-0.62
Price to Earning Ratio
-0.7x
Price To Sales Ratio
17.5x
POCF Ratio
-0.7
PFCF Ratio
-0.69
Price to Book Ratio
0.68
EV to Sales
-8.03
EV Over EBITDA
0.3
EV to Operating CashFlow
0.32
EV to FreeCashFlow
0.32
Earnings Yield
-1.43
FreeCashFlow Yield
-1.44
Market Cap
0,03 Bil.
Enterprise Value
-0,02 Bil.
Graham Number
2.98
Graham NetNet
0.59

Income Statement Metrics

Net Income per Share
-0.62
Income Quality
1
ROE
-0.74
Return On Assets
-0.72
Return On Capital Employed
-1
Net Income per EBT
1
EBT Per Ebit
0.86
Ebit per Revenue
-28.87
Effective Tax Rate
-0.08

Margins

Sales, General, & Administrative to Revenue
0.64
Research & Developement to Revenue
9.25
Stock Based Compensation to Revenue
2.75
Gross Profit Margin
0.56
Operating Profit Margin
-28.87
Pretax Profit Margin
-24.92
Net Profit Margin
-24.92

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.62
Free CashFlow per Share
-0.63
Capex to Operating CashFlow
0.01
Capex to Revenue
-0.19
Capex to Depreciation
-1.23
Return on Invested Capital
-0.98
Return on Tangible Assets
-0.72
Days Sales Outstanding
26.98
Days Payables Outstanding
470.02
Days of Inventory on Hand
0
Receivables Turnover
13.53
Payables Turnover
0.78
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
0,81
Book Value per Share
0,64
Tangible Book Value per Share
0.64
Shareholders Equity per Share
0.64
Interest Debt per Share
0.18
Debt to Equity
0.24
Debt to Assets
0.18
Net Debt to EBITDA
0.95
Current Ratio
5.8
Tangible Asset Value
0,05 Bil.
Net Current Asset Value
0,05 Bil.
Invested Capital
0.24
Working Capital
0,05 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0.5
Debt to Market Cap
0.35

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Akili, Inc. Dividends
Year Dividends Growth

Akili, Inc. Profile

About Akili, Inc.

Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. The company is based in Boston, Massachusetts.

CEO
Mr. Matthew Franklin M.B.A.
Employee
68
Address
125 Broad Street
Boston, 02110

Akili, Inc. Executives & BODs

Akili, Inc. Executives & BODs
# Name Age
1 Mr. Matthew Franklin M.B.A.
President, Chief Executive Officer & Director
70
2 Dr. Walter Edward Martucci II, Ph.D.
Co-Founder & Chairman
70
3 Mr. Jonathan David
Chief Product Officer
70
4 Dr. Adam Gazzaley M.D., Ph.D.
Co-Founder, Chief Science Advisor & Director
70
5 Ms. Jacqueline L. Studer J.D.
Chief Legal Officer, General Counsel & Secretary
70

Akili, Inc. Competitors